Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 9;12(16):7080-7107.
doi: 10.7150/thno.75937. eCollection 2022.

Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer

Affiliations
Review

Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer

Xiaomeng Tang et al. Theranostics. .

Abstract

Digestive system cancer is the most common cause of cancer death in the world. Although cancer treatment options are increasingly diversified, the mortality rate of malignant cancer of the digestive system remains high. Therefore, it is necessary to explore effective cancer treatment methods. Recently, biomimetic nanoparticle delivery systems based on natural cells that organically integrate the low immunogenicity, high biocompatibility, cancer targeting, and controllable, versatile functionality of smart nanocarrier design with natural cells have been expected to break through the bottleneck of tumor targeted therapy. In this review, we focus on the dynamic changes and complex cellular communications that occur in vivo in natural cells based vehicles. Recent studies on the development of advanced targeted drug delivery systems using the dynamic behaviors such as specific surface protein affinity, morphological changes, and phenotypic polarization of natural cells are summarized. In addition to drug delivery mediated by dynamic behavior, functional "delivery" based on the natural cell themselves is also involved. Aiming to make the best use of the functions of cells, providing clues for the development of advanced drug delivery platforms.

Keywords: Biomimetic cellular transformers; Cancer targeting; Digestive system cancer; Natural cell; Transformation.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Schematic representation of biomimetic cellular transformers.
Figure 2
Figure 2
Clinically translatable nanocarriers adsorb onto red blood cells. (a) Procedural steps of RBC hitchhiking. NCs are first adsorbed onto the RBCs ex vivo. (b) Scanning electron micrographs of PS-NPs and nanogels attached to the surface of murine RBCs. Adapted with permission from . Copyright Year 2018, Springer Nature.
Figure 3
Figure 3
Schematic illustration showing the chemotaxis-driven delivery of NPNs for complete eradication of tumors post-phototherapy. #1a The released G-CSF and GM-CSF increased neutrophil production from bone marrow. #1b The released CXCL1 and MIP-2 broadcasted the location of the inflamed tumor. #2 Neutrophils entered the blood circulation and encountered the injected NPNs. #3 Neutrophils sensed NPNs with the recognition of LPS and lipoprotein by TLRs and subsequently engulfed them. #4 Neutrophils laden with NPNs were recruited into the tumor site in response to the chemokine gradient through the following cascade: adhesion, crawling and transmigration. #5 NPNs were released from neutrophils to kill tumor cells along with the formation of NETs in the inflamed tumor. Adapted with permission from . Copyright Year 2020, Springer Nature.
Figure 4
Figure 4
Liposome-based cellular engineering for efficient intracellular packaging of cargo in extracellular vesicles. Adapted with permission from . Copyright Year 2016, American Chemical Society.
Figure 5
Figure 5
Grapefruit-derived nanoparticles (GDN) pretreatment ameliorates DSS-induced colitis in mice. C57/B6 mice were treated with either PBS/DSS or GDN/DSS. Adapted with permission from . Copyright Year 2014, Elsevier.
Figure 6
Figure 6
Schematic Illustration of the Bioengineering Process of Functionalized OMV-Coated Polymeric Micelles and Their Proposed Mechanism of Immunotherapy for Protective Immunity, Cancer Treatment, and Metastasis Preventiona. Adapted with permission from . Copyright Year 2020, American Chemical Society.
Figure 7
Figure 7
Schematic design of drug-loaded PM-NV for targeting and sequential drug delivery. Adapted with permission from . Copyright Year 2015, Wiley-VCH GmbH.
Figure 8
Figure 8
Reprogramming of tumor-associated macrophages by iron oxide nanoparticles as an anti-tumor therapeutic strategy . Copyright Year 2021, the Authors.
Figure 9
Figure 9
Schematic illustration of platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Adapted with permission from . Copyright Year 2020, Wiley-VCH GmbH.
Figure 10
Figure 10
Schematic illustration of N3-labeled T cell membrane-biomimetic nanoparticles with dual-targeting mechanism for highly efficient photothermal therapy. Adapted with permission from . Copyright Year 2019, Wiley-VCH GmbH.
Figure 11
Figure 11
Schematic diagram of the construction of bionic cascaded-enzyme nanoreactor and proposed mechanism in vivo. Adapted with permission from . Copyright Year 2021, Springer Nature.

Similar articles

Cited by

References

    1. Mizrahi J, Pant S. Immunotherapy in Gastrointestinal Malignancies. Adv Exp Med Biol. 2020;1244:93–106. - PubMed
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49. - PubMed
    1. Mehrling T. Chemotherapy is getting 'smarter'. Future Oncol. 2015;11:549–52. - PubMed
    1. Turkes F, Mencel J, Starling N. Targeting the immune milieu in gastrointestinal cancers. J Gastroenterol. 2020;55(10):909–926. - PMC - PubMed
    1. Barsouk A, Thandra KC, Saginala K, Rawla P, Barsouk A. Chemical Risk Factors of Primary Liver Cancer: An Update. Hepat Med. 2020;12:179–188. - PMC - PubMed

Publication types

Substances